A detailed history of Juncture Wealth Strategies, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Juncture Wealth Strategies, LLC holds 8,525 shares of GILD stock, worth $750,882. This represents 0.28% of its overall portfolio holdings.

Number of Shares
8,525
Previous 7,092 20.21%
Holding current value
$750,882
Previous $486,000 46.91%
% of portfolio
0.28%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$66.59 - $83.99 $95,423 - $120,357
1,433 Added 20.21%
8,525 $714,000
Q2 2024

Jul 11, 2024

BUY
$63.15 - $72.88 $170,820 - $197,140
2,705 Added 61.66%
7,092 $486,000
Q1 2024

Apr 05, 2024

BUY
$71.58 - $87.29 $314,021 - $382,941
4,387 New
4,387 $321,000
Q2 2019

Jul 16, 2019

SELL
$61.87 - $69.38 $194,766 - $218,408
-3,148 Closed
0 $0
Q1 2019

Apr 09, 2019

BUY
$62.53 - $70.05 $196,844 - $220,517
3,148 New
3,148 $205,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Juncture Wealth Strategies, LLC Portfolio

Follow Juncture Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Juncture Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Juncture Wealth Strategies, LLC with notifications on news.